EcoDrugPlus

Histone Deacetylase 2

Ensembl ID : ENSMSIG00000004652
Gene Symbol: HDAC2
1 Cross references
227 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSMSIG00000026000
Gene Symbol: HDAC3
1 Cross references
171 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSMSIG00000013672
Gene Symbol: HDAC4
1 Cross references
278 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSMSIG00000028119
Gene Symbol: HDAC5
1 Cross references
209 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSMSIG00000027292
Gene Symbol: HDAC7
1 Cross references
275 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSMSIG00000024883
Gene Symbol: HDAC8
1 Cross references
216 Possible Orthologues:

Histone Deacetylase 9

Ensembl ID : ENSMSIG00000007205
Gene Symbol: HDAC9
1 Cross references
237 Possible Orthologues:

Hydroxycarboxylic Acid Receptor 2

Ensembl ID : ENSMSIG00000014676
Gene Symbol: HCAR2
1 Cross references
180 Possible Orthologues:

Hydroxysteroid 11-Beta Dehydrogenase 1

Ensembl ID : ENSMSIG00000024176
Gene Symbol: HSD11B1
1 Cross references
263 Possible Orthologues:

Hyperpolarization-Activated, Cyclic Nucleotide-Gated K+ 4

Ensembl ID : ENSMSIG00000006733
Gene Symbol: HCN4
1 Cross references
302 Possible Orthologues:

Hypocretin (Orexin) Receptor 1

Ensembl ID : ENSMSIG00000023482
Gene Symbol: HCRTR1
1 Cross references
111 Possible Orthologues:

Hypocretin (Orexin) Receptor 2

Ensembl ID : ENSMSIG00000029662
Gene Symbol: HCRTR2
1 Cross references
216 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).